Table 2.
Descriptive statistics of general and diabetes-related health indicators before and after using the platform for 8 weeks.
| Health indicator | Before platform use (n=73) | After 8 weeks of platform use (n=23) | |||
|
|
Value, n (%) | Value, mean (SD) | Value, n (%) | Value, mean (SD) | |
| General health (scale 0-100) | 72 (99) | 66.1 (20.0) | 23 (100) | 67.6 (21.7) | |
| Height (m) | 70 (96) | 1.7 (0.1) | N/Aa | N/A | |
| Weight (kg) | 70 (96) | 91.0 (22.6) | 23 (100) | 89.5 (25.6) | |
| BMI (kg/m²) | 70 (96) | 27.2 (6.7) | 23 (100) | 32.7 (9.3) | |
| Waist size (cm) | 57 (78) | 101.0 (17.0) | 18 (78) | 94.4 (16.4) | |
| Blood glucose level (HbA1cb, mmol/mol)c | 44 (60) | 37.2 (31.1) | 13 (57) | 32.9 (27.0) | |
| Blood pressure, systolic (mm Hg) | 36 (49) | 132.3 (13.7) | 9 (39) | 122.2 (7.6) | |
| Blood pressure, diastolic (mm Hg) | 35 (48) | 78.2 (9.5) | 9 (39) | 75.9 (5.9) | |
| HDLd cholesterol level (mmol/L)e | 7 (10) | 3.5 (1.7) | —f | — | |
| Total cholesterol level (mmol/L) | 15 (21) | 4.9 (0.7) | — | — | |
aN/A: not applicable (height was not measured after 8 weeks of using the platform, given that this is a stable trait).
bHbA1c: glycated hemoglobin.
cMedian 42.0 (IQR 7.6-50.75).
dHDL: high-density lipoprotein.
eMedian 3.6 (IQR 1.57-5.10).
fHDL and total cholesterol levels are not reported after 8 weeks of using the platform, given that only 2 (9%) of the 23 participants reported these.